Integrin β4 as a potential diagnostic and therapeutic tumor marker

15Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Integrin β4 (ITGβ4) is a class of transmembrane adhesion molecules composed of hemide-smosomes (HDs). Its unique long intracellular domain provides intricate signal transduction func-tions. These signal transduction effects are especially prominent in tumors. Many recent studies have shown that integrin β4 is differentially expressed in various tumors, and it plays a vital role in tumor invasion, proliferation, epithelial–mesenchymal transition, and angiogenesis. Therefore, we categorize the research related to integrin β4, starting from its structure and function in tumor tissues, and provide a basic description. Based on its structure and function, we believe that integrin β4 can be used as a tumor marker. In clinical practice, it is described as a diagnostic marker for the targeted treatment of cancer and will be helpful in the clinical diagnosis and treatment of tumors.

Cite

CITATION STYLE

APA

Yang, H., Xu, Z., Peng, Y., Wang, J., & Xiang, Y. (2021, August 1). Integrin β4 as a potential diagnostic and therapeutic tumor marker. Biomolecules. MDPI AG. https://doi.org/10.3390/biom11081197

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free